Steris Share Price (NYSE: STE)

$245.14

▲

0.37

(0.15%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Steris Stock chart to analyse performance

Steris stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$244.59
Today's High:$246.44
$245.14
0.22%
Downside
Day's Volatility :0.75%
Upside
0.53%
52 Weeks Low:$200.98
52 Weeks High:$252.79
$245.14
18.01%
Downside
52 Weeks Volatility :20.5%
Upside
3.03%

Steris Stock Returns

Period	Steris Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	1.23%	3.6%	0.0%
6 Months	10.03%	-7.7%	0.0%
1 Year	0.79%	-12.6%	0.0%
3 Years	23.04%	8.4%	-3.0%

Steris Corp. Key Stats

Check Steris key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$244.77
Open	$246.4
Today's High	$246.44
Today's Low	$244.59
Market Capitalization	$24.1B
Today's Volume	$561.7K
52 Week High	$252.79
52 Week Low	$200.98
Revenue TTM	$5.6B
EBITDA	$1.5B
Earnings Per Share (EPS)	$6.54
PE Ratio	37.47
Dividend Yield	0.93%
Profit Margin	11.61%
Quarterly Earnings Growth YOY	0.22%
Return On Equity TTM	9.74%

Stock Returns calculator for Steris Stock including INR - Dollar returns

The Steris stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Steris investment value today

Current value as on today

₹1,05,989

Returns

₹5,989

(+5.99%)

Returns from Steris Stock

₹818 (+0.82%)

Dollar Returns*

₹5,171 (+5.17%)

Indian investors sentiment towards Steris Stock

-36%

Period: Aug 1, 2025 to Aug 31, 2025. Change in 30 Days versus previous period

Search interest for Steris Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Steris Stock

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	794	0.13	0.04%

Global Institutional Holdings in Steris Corp.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
12.35%
BlackRock Inc
9.35%
Massachusetts Financial Services Company
5.33%
State Street Corp
4.15%
Morgan Stanley - Brokerage Accounts
3.95%
Generation Investment Management LLP
3.22%

Analyst Recommendation on Steris Stock

Rating

Trend

Buy

58%Buy

41%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Steris(by analysts ranked 0 to 5 stars)

Steris Share Price Target

What analysts predicted

Upside of 11.11%

Target:

$272.38

Current:

$245.14

Steris share price target is $272.38, a slight Upside of 11.11% compared to current price of $245.14 as per analysts' prediction.

Steris Stock Insights

Price Movement
In the last 7 days, STE stock has moved down by -1.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 1.48B → 1.39B (in $), with an average decrease of 6.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 145.67M → 177.4M (in $), with an average increase of 17.9% per quarter
STE vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 27.4%
STE vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 157.4% return, outperforming this stock by 135.0%
Price to Sales
ForSTE every $1 of sales, investors are willing to pay $4.3, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Steris Corp. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Revenue	$3.0B	↑ 8.94%
Net Income	$407.7M	↑ 34.08%
Net Profit Margin	13.45%	↑ 2.52%

	FY21	Y/Y Change
Revenue	$3.1B	↑ 2.53%
Net Income	$397.4M	↓ 2.52%
Net Profit Margin	12.79%	↓ 0.66%

	FY22	Y/Y Change
Revenue	$4.2B	↑ 35.91%
Net Income	$243.9M	↓ 38.63%
Net Profit Margin	5.77%	↓ 7.02%

	FY23	Y/Y Change
Revenue	$4.5B	↑ 7.41%
Net Income	$107.0M	↓ 56.12%
Net Profit Margin	2.36%	↓ 3.41%

	FY24	Y/Y Change
Revenue	$5.1B	↑ 13.28%
Net Income	$378.2M	↑ 253.4%
Net Profit Margin	7.36%	↑ 5.0%

	FY25	Y/Y Change
Revenue	$5.5B	↑ 6.24%
Net Income	$614.6M	↑ 62.5%
Net Profit Margin	11.26%	↑ 3.9%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.1B	↓ 13.99%
Net Income	$-1.4M	↓ 100.98%
Net Profit Margin	-0.12%	↓ 10.97%

	Q2 FY24	Q/Q Change
Revenue	$1.3B	↑ 14.63%
Net Income	$145.4M	↓ 10659.26%
Net Profit Margin	11.36%	↑ 11.48%

	Q3 FY24	Q/Q Change
Revenue	$1.3B	↑ 3.86%
Net Income	$150.0M	↑ 3.19%
Net Profit Margin	11.29%	↓ 0.07%

	Q4 FY24	Q/Q Change
Revenue	$1.4B	↑ 3.13%
Net Income	$173.5M	↑ 15.66%
Net Profit Margin	12.66%	↑ 1.37%

	Q1 FY25	Q/Q Change
Revenue	$1.5B	↑ 8.02%
Net Income	$145.7M	↓ 16.06%
Net Profit Margin	9.84%	↓ 2.82%

	Q2 FY25	Q/Q Change
Revenue	$1.4B	↓ 6.04%
Net Income	$177.4M	↑ 21.78%
Net Profit Margin	12.75%	↑ 2.91%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Profit	$1.3B	↑ 12.34%

	FY21	Y/Y Change
Profit	$1.3B	↑ 1.75%

	FY22	Y/Y Change
Profit	$1.9B	↑ 40.2%

	FY23	Y/Y Change
Profit	$2.0B	↑ 5.19%

	FY24	Y/Y Change
Profit	$2.2B	↑ 11.99%

	FY25	Y/Y Change
Profit	$2.4B	↑ 8.32%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$448.6M	↓ 19.9%

	Q2 FY24	Q/Q Change
Profit	$572.4M	↑ 27.6%

	Q3 FY24	Q/Q Change
Profit	$578.8M	↑ 1.12%

	Q4 FY24	Q/Q Change
Profit	$610.3M	↑ 5.45%

	Q1 FY25	Q/Q Change
Profit	$641.2M	↑ 5.06%

	Q2 FY25	Q/Q Change
Profit	$628.0M	↓ 2.06%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Operating Cash Flow	$590.6M	↑ 9.46%
Investing Cash Flow	$-319.7M	↑ 49.95%
Financing Cash Flow	$-163.1M	↓ 44.66%

	FY21	Y/Y Change
Operating Cash Flow	$689.6M	↑ 16.78%
Investing Cash Flow	$-1.2B	↑ 260.97%
Financing Cash Flow	$345.6M	↓ 311.85%

	FY22	Y/Y Change
Operating Cash Flow	$684.8M	↓ 0.7%
Investing Cash Flow	$-666.6M	↓ 42.25%
Financing Cash Flow	$115.8M	↓ 66.49%

	FY23	Y/Y Change
Operating Cash Flow	$756.9M	↑ 10.53%
Investing Cash Flow	$-383.3M	↓ 42.49%
Financing Cash Flow	$-498.7M	↓ 530.56%

	FY24	Y/Y Change
Operating Cash Flow	$973.3M	↑ 28.58%
Investing Cash Flow	$-887.4M	↑ 131.49%
Financing Cash Flow	$-85.2M	↓ 82.92%

	FY25	Y/Y Change
Operating Cash Flow	$1.1B	↑ 17.96%
Investing Cash Flow	$388.8M	↓ 143.81%
Financing Cash Flow	$-1.6B	↑ 1745.8%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$254.8M	↓ 12.51%
Investing Cash Flow	$-95.6M	↓ 19.6%
Financing Cash Flow	$-143.8M	↓ 27.39%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$303.7M	↑ 19.21%
Investing Cash Flow	$687.8M	↓ 819.43%
Financing Cash Flow	$-998.9M	↑ 594.82%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$250.7M	↓ 17.45%
Investing Cash Flow	$-105.4M	↓ 115.32%
Financing Cash Flow	$-181.0M	↓ 81.88%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$332.8M	↑ 32.75%
Investing Cash Flow	$-123.9M	↑ 17.61%
Financing Cash Flow	$-214.4M	↑ 18.47%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$260.8M	↓ 21.65%
Investing Cash Flow	$-69.8M	↓ 43.67%
Financing Cash Flow	$-178.1M	↓ 16.94%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$420.0M	↑ 61.05%
Investing Cash Flow	$-108.5M	↑ 55.44%
Financing Cash Flow	$-213.1M	↑ 19.67%

Steris Technicals Summary

Sell

Neutral

Buy

Steris is currently in a neutral trading position according to technical analysis indicators.

Steris Corp. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Steris Corp.	7.28%	10.03%	0.79%	23.04%	49.84%
Medtronic Plc	3.54%	-1.58%	4.33%	6.43%	-14.68%
Edwards Lifesciences Corp.	1.56%	13.94%	18.31%	-8.29%	-6.98%
Boston Scientific Corp.	-1.21%	0.6%	30.02%	160.56%	149.82%
Stryker Corporation	2.6%	-0.88%	8.84%	92.09%	94.13%
Abbott Laboratories	2.1%	-5.39%	15.7%	29.42%	21.22%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Steris Corp.	37.47	37.47	1.86	9.06	0.1	0.06	0.01	70.63
Medtronic Plc	25.64	25.64	2.16	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.86	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.8	62.8	1.83	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.84	51.84	2.23	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Steris Corp.	Buy	$24.1B	49.84%	37.47	11.61%
Medtronic Plc	Buy	$119.0B	-14.68%	25.64	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-6.98%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.3B	149.82%	62.8	13.55%
Stryker Corporation	Buy	$149.6B	94.13%	51.84	12.25%
Abbott Laboratories	Buy	$230.9B	21.22%	16.64	32.43%

Steris Dividend announcements

Steris Dividends September, 2025
In the quarter ending September,2025. Steris has declared dividend of $0.63

About Steris Corp.

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Organization	Steris
Employees	17787
CEO	Mr. Daniel A. Carestio
Industry	Health Technology

Key Management of Steris Corp.

Name	Title
Mr. Daniel A. Carestio	President, CEO & Director
Mr. John Adam Zangerle	Senior VP, General Counsel & Secretary
Ms. Mary Clare Fraser	SVP & Chief Human Resources Officer
Mr. Cary L. Majors	Senior VP & President of Healthcare
Ms. Karen L. Burton	Senior VP, CFO & Chief Accounting Officer
Ms. Julie Winter	Vice President of Investor Relations & Corporate Communications
Ms. Julia K. Madsen	Senior VP & GM of Life Sciences
Mr. Andrew Xilas	Senior VP & GM of Dental
Mr. Kenneth E. Kohler	Senior VP & GM of AST
Mr. Renato G. Tamaro	VP & Corporate Treasurer

Important FAQs about investing in STE Stock from India :

What is Steris share price today?

Steris share price today is $245.14 as on August 30, 2025 at 1:29 am IST at the close of the market. Steris share today touched a day high of $246.44 and a low of $244.59.

What is the 52 week high and 52 week low for Steris share?

Steris share touched a 52 week high of $252.79 and a 52 week low of $200.98. Steris stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $245.14, lower by 3.03% versus the 52 week high.

How to invest in Steris Stock (STE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Steris on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Steris Shares that will get you 0.0061 shares as per Steris share price of $245.14 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Steris Stock (STE) from India?

Indian investors can start investing in Steris (STE) shares with as little as ₹88.191 or $1 (as of September 01, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.91 in Steris stock (as per the Rupee-Dollar exchange rate as on September 01, 2025). Based on Steris share’s latest price of $245.14 as on August 30, 2025 at 1:29 am IST, you will get 0.0408 shares of Steris. Learn more about fractional shares .

What are the returns that Steris has given to Indian investors in the last 5 years?

Steris stock has given 49.84% share price returns and 20.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?